Debruyne FM - Search Results

1

Intravesical instillation therapy: alternative treatments.

Debruyne FM, van der Meijden AP, Witjes JA. Debruyne FM, et al. Recent Results Cancer Res. 1993;126:119-25. doi: 10.1007/978-3-642-84583-3_11. Recent Results Cancer Res. 1993. PMID: 8456182 Review. No abstract available.

2

Intravesical chemotherapy for superficial bladder cancer.

Witjes JA, Debruyne FM. Witjes JA, et al. Among authors: debruyne fm. Nat Clin Pract Urol. 2004 Dec;1(2):56-7. doi: 10.1038/ncpuro0009. Nat Clin Pract Urol. 2004. PMID: 16474497 No abstract available.

3

BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group.

Debruyne FM, van der Meijden AP, Franssen MP. Debruyne FM, et al. Prog Clin Biol Res. 1989;303:435-46. Prog Clin Biol Res. 1989. PMID: 2506556 Clinical Trial. No abstract available.

4

Aspects of non-specific immunotherapy with BCG in superficial bladder cancer: an overview.

van der Meijden AP, Debruyne FM, Steerenberg PA, de Jong WH. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:11-33. Prog Clin Biol Res. 1989. PMID: 2672011 Review. No abstract available.

5

Intravesical BCG administration in the guinea pig. Histomorphological aspects.

van der Meijden AP, de Jong WH, Steerenberg PA, Debruyne FM, Ruitenberg JE. van der Meijden AP, et al. Among authors: debruyne fm. Prog Clin Biol Res. 1989;310:67-79. Prog Clin Biol Res. 1989. PMID: 2672024 No abstract available.

6

Intravesical BCG administration in the guinea pig. A histomorphological study.

van der Meijden AP, de Jong WH, Steerenberg PA, Walvoort HC, de Boer EC, Debruyne FM, Ruitenberg EJ. van der Meijden AP, et al. Among authors: debruyne fm. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988;55(4):207-15. doi: 10.1007/BF02896577. Virchows Arch B Cell Pathol Incl Mol Pathol. 1988. PMID: 2900573

7

Immunological aspects of intravesical administration of Bacillus Calmette-Guérin (BCG) in the guinea pig.

van der Meijden AP, de Jong WH, de Boer EC, Steerenberg PA, Debruyne FM, Ruitenberg EJ. van der Meijden AP, et al. Among authors: debruyne fm. Urol Res. 1989;17(1):47-55. doi: 10.1007/BF00261051. Urol Res. 1989. PMID: 2922891

8

Intravesical and intradermal Bacillus Calmette-Guérin application. A phase I study to the toxicity of a Dutch Bacillus Calmette-Guérin preparation in patients with superficial bladder cancer.

Schreinemachers LM, van der Meijden AP, Wagenaar J, Steerenberg PA, Feitz WF, Groothuis DG, Tiesjema RH, de Jong WH, Debruyne FM, Ruitenberg EJ. Schreinemachers LM, et al. Among authors: debruyne fm. Eur Urol. 1988;14(1):15-21. Eur Urol. 1988. PMID: 2963745

9

Treatment schedule of intravesical chemotherapy with mitomycin C in superficial bladder cancer: short-term courses or maintenance therapy.

van der Meijden AP, DeBruyne FM. van der Meijden AP, et al. Among authors: debruyne fm. Urology. 1988 Mar;31(3 Suppl):26-9. Urology. 1988. PMID: 3126592 Review.

10

BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer.

Debruyne FM, van der Meijden AP, Schreinemachers LM, Geboers AD, Franssen MP, van Leeuwen MJ, Steerenberg PA, de Jong WH, Ruitenberg EJ. Debruyne FM, et al. Prog Clin Biol Res. 1988;269:511-24. Prog Clin Biol Res. 1988. PMID: 3134662 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

663 results

Search Page